CCB
MLAB icon

Cutter & Co Brokerage’s Mesa Laboratories MLAB Stock Holding History

Cutter & Co Brokerage’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,245
Closed -$218K – 218
2023
Q1 		$218K Sell
1,245
-150
-11% -$26.9K 0.07% 183
2022
Q4 		$232K Buy
+1,395
New +$219K 0.08% 174
2022
Q3 		– Sell
-1,365
Closed -$278K – 231
2022
Q2 		$278K Buy
+1,365
New +$299K 0.09% 168

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Cutter & Co Brokerage's MLAB Position: Q2 2023 in Review

Cutter & Co Brokerage sold out of Mesa Laboratories (MLAB) in Q2 2023, closing a stake of 1,245 shares — an estimated $218K sold.

Cutter & Co Brokerage first reported a position in MLAB in Q2 2022 and held it in 3 quarters. The position peaked at $278K in Q2 2022. 161 funds tracked by Wall St. Rank hold MLAB as of Q2 2023.

  • Cutter & Co Brokerage reported no remaining Mesa Laboratories position as of Q2 2023 after selling out during the quarter.
  • Cutter & Co Brokerage sold 1,245 Mesa Laboratories shares in Q2 2023, an estimated $218K.
  • Cutter & Co Brokerage first reported a position in Mesa Laboratories in Q2 2022 and held it in 3 quarters.
  • Cutter & Co Brokerage's Mesa Laboratories position peaked at $278K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2023.

Based on Cutter & Co Brokerage's 13F filing for Q2 2023, filed 1 Aug 2023.